PharmaShots | Incisive News in 3 Shots

Subscribe Now

orbus therapeutics

Orbus Therapeutics Reports the P-III (STELLAR) Trial Data of Eflornithine Plus Lomustine to Treat Recurrent Astrocytoma IDH Mutant Grade 3

Orbus Therapeutics Reports the P-III (STELLAR) Trial Data of Eflornithine Plus Lomustine to Treat Recurrent Astrocytoma IDH Mutant...

November 25, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us